We estimate that the CEO of NEOGENOMICS INC ($NEO), Christopher Smith, received a compensation of $4,045,937 in 2025. This is a decrease of -180.24% from an estimated $11,338,487 in 2024.
These estimates are based on a new DEF14A filing, filed with the SEC on April 06, 2026. Note that parsing errors may occur.
You can track $NEO on Quiver Quantitative's $NEO stock dashboard.
$NEO Stock Insider Trading Activity
$NEO Stock insiders have traded $NEO stock on the open market 3 times in the past 6 months. Of those trades, 0 have been purchases and 3 have been sales.
Here’s a breakdown of recent trading of $NEO stock by insiders over the last 6 months:
- ALICIA C OLIVO (EVP, GC & Business Development) has made 0 purchases and 2 sales selling 25,834 shares for an estimated $300,172.
- WARREN STONE (Pres & Chief Operating Officer) sold 22,128 shares for an estimated $276,681
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$NEO Stock Government Contracts
We have seen $3,970,076 of award payments to $NEO over the last year.
Here are some of the awards which we have have seen pay out the most over the last year:
- STX SPECIALIZED REFERENCE LABORATORY TESTING: $2,787,350
- TASK ORDER FOR SERVICES ORDERING PERIOD 5 OFF-SITE ANATOMIC PATHOLOGY LAB SERVICES VACCHCS: $325,000
- IMMUNOHISTOCHEMISTRY (IHC) TESTING: $211,500
- IMMUNOHISTOLOGICAL STAINS REFERENCE TESTING: $108,000
- [25-010222] HEMATOLOGY BRANCH/WIESTNER LABORATORY REQUIRES HUMAN GENOMICS TESTING SERVICES IN ORDER TO DIAG...: $24,614
To track government contracts to publicy traded companies, check out Quiver Quantitative's government contracts dashboard.
$NEO Stock Hedge Fund Activity
We have seen 108 institutional investors add shares of $NEO Stock stock to their portfolio, and 121 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- DEERFIELD MANAGEMENT COMPANY, L.P. removed 4,447,331 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $52,300,612
- BRAIDWELL LP added 2,861,655 shares (+161.6%) to their portfolio in Q4 2025, for an estimated $33,653,062
- MACQUARIE GROUP LTD removed 2,542,339 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $29,897,906
- DRIEHAUS CAPITAL MANAGEMENT LLC added 2,471,738 shares (+inf%) to their portfolio in Q4 2025, for an estimated $29,067,638
- D. E. SHAW & CO., INC. added 2,000,123 shares (+60.7%) to their portfolio in Q4 2025, for an estimated $23,521,446
- LOOMIS SAYLES & CO L P added 1,631,135 shares (+inf%) to their portfolio in Q4 2025, for an estimated $19,182,147
- CITADEL ADVISORS LLC removed 1,403,320 shares (-51.8%) from their portfolio in Q4 2025, for an estimated $16,503,043
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$NEO Stock Analyst Ratings
Wall Street analysts have issued reports on $NEO in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Needham issued a "Buy" rating on 02/17/2026
To track analyst ratings and price targets for $NEO Stock, check out Quiver Quantitative's $NEO forecast page.
$NEO Stock Price Targets
Multiple analysts have issued price targets for $NEO recently. We have seen 2 analysts offer price targets for $NEO in the last 6 months, with a median target of $14.0.
Here are some recent targets:
- David Westenberg from Piper Sandler set a target price of $13.0 on 02/24/2026
- Mike Matson from Needham set a target price of $15.0 on 02/17/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
